Spotty calcification as a marker of accelerated progression of <font color="blue">coronary_1</font> <font color="blue">atherosclerosis_1</font> <font color="blue">:_1</font> insights from serial intravascular ultrasound . 
<br>
<br> OBJECTIVES The purpose of this study was to <font color="blue">determine_1</font> <font color="blue">atheroma_2</font> <font color="blue">progression_2</font> <font color="blue">in_2</font> <font color="blue">patients_4</font> <font color="blue">with_4</font> <font color="blue">spotty_4</font> <font color="blue">calcification_4</font> <font color="blue">._4</font> <font color="blue">
<br>_1</font> BACKGROUND Although extensively calcified atherosclerotic lesions have been proposed to be clinically quiescent , the presence of spotty calcification within plaque has been reported to be associated with an increased incidence of ischemic cardiovascular events . The relationship between spotty calcification and disease progression has not been investigated . 
<br> METHODS <font color="blue">A_1</font> <font color="blue">total_3</font> <font color="blue">of_3</font> <font color="blue">1,347_6</font> <font color="blue">stable_6</font> <font color="blue">patients_6</font> <font color="blue">with_6</font> <font color="blue">angiographic_6</font> <font color="blue">coronary_6</font> <font color="blue">artery_6</font> <font color="blue">disease_6</font> <font color="blue">underwent_2</font> <font color="blue">serial_2</font> <font color="blue">evaluation_2</font> <font color="blue">of_2</font> <font color="blue">atheroma_2</font> <font color="blue">burden_2</font> <font color="blue">with_2</font> <font color="blue">intravascular_2</font> <font color="blue">ultrasound_2</font> <font color="blue">imaging_2</font> <font color="blue">._2</font> <font color="blue">Patients_3</font> <font color="blue">with_3</font> <font color="blue">spotty_3</font> <font color="blue">calcification_3</font> <font color="blue">were_3</font> <font color="blue">identified_3</font> <font color="blue">based_3</font> <font color="blue">on_3</font> <font color="blue">the_3</font> <font color="blue">presence_3</font> <font color="blue">of_3</font> <font color="blue">lesions_3</font> <font color="blue">(_3</font> <font color="blue">1_3</font> <font color="blue">to_3</font> <font color="blue">4_3</font> <font color="blue">mm_3</font> <font color="blue">in_3</font> <font color="blue">length_3</font> <font color="blue">)_3</font> <font color="blue">containing_3</font> <font color="blue">an_3</font> <font color="blue">arc_3</font> <font color="blue">of_3</font> <font color="blue">calcification_3</font> <font color="blue">of_3</font> <font color="blue"><_3</font> <font color="blue">90°._3</font> Clinical characteristics and disease progression were <font color="blue">compared_1</font> <font color="blue">between_1</font> <font color="blue">patients_3</font> <font color="blue">with_3</font> <font color="blue">spotty_3</font> <font color="blue">calcification_3</font> <font color="blue">(_3</font> <font color="blue">n_3</font> <font color="blue">=_3</font> <font color="blue">922_3</font> <font color="blue">)_3</font> <font color="blue">and_2</font> <font color="blue">those_2</font> <font color="blue">with_2</font> <font color="blue">no_2</font> <font color="blue">calcification_2</font> <font color="blue">(_2</font> <font color="blue">n_2</font> <font color="blue">=_2</font> <font color="blue">425_2</font> <font color="blue">)_2</font> <font color="blue">._2</font> 
<br> RESULTS <font color="blue">Patients_2</font> <font color="blue">with_2</font> <font color="blue">spotty_2</font> <font color="blue">calcification_2</font> <font color="blue">were_1</font> <font color="blue">older_2</font> <font color="blue">(_2</font> <font color="blue">age_2</font> <font color="blue">56_2</font> <font color="blue">years_2</font> <font color="blue">vs._2</font> <font color="blue">54_2</font> <font color="blue">years_2</font> <font color="blue">;_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.001_2</font> <font color="blue">)_2</font> <font color="blue">,_2</font> <font color="blue">more_2</font> <font color="blue">likely_2</font> <font color="blue">to_2</font> <font color="blue">be_2</font> <font color="blue">male_2</font> <font color="blue">(_2</font> <font color="blue">68%_2</font> <font color="blue">vs._2</font> <font color="blue">54%_2</font> <font color="blue">;_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.01_2</font> <font color="blue">)_2</font> <font color="blue">,_2</font> <font color="blue">and_2</font> <font color="blue">have_2</font> <font color="blue">a_2</font> <font color="blue">history_2</font> <font color="blue">of_2</font> <font color="blue">diabetes_2</font> <font color="blue">mellitus_2</font> <font color="blue">(_2</font> <font color="blue">30%_2</font> <font color="blue">vs._2</font> <font color="blue">24%_2</font> <font color="blue">;_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.01_2</font> <font color="blue">)_2</font> <font color="blue">and_2</font> <font color="blue">myocardial_2</font> <font color="blue">infarction_2</font> <font color="blue">(_2</font> <font color="blue">28%_2</font> <font color="blue">vs._2</font> <font color="blue">20%_2</font> <font color="blue">;_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.004_2</font> <font color="blue">)_2</font> <font color="blue">,_2</font> <font color="blue">and_2</font> <font color="blue">have_2</font> <font color="blue">lower_2</font> <font color="blue">on_2</font> <font color="blue">-_2</font> <font color="blue">treatment_2</font> <font color="blue">high_2</font> <font color="blue">-_2</font> <font color="blue">density_2</font> <font color="blue">lipoprotein_2</font> <font color="blue">cholesterol_2</font> <font color="blue">levels_2</font> <font color="blue">(_2</font> <font color="blue">48_2</font> <font color="blue">±_2</font> <font color="blue">16_2</font> <font color="blue">mg_2</font> <font color="blue">/_2</font> <font color="blue">dl_2</font> <font color="blue">vs._2</font> <font color="blue">51_2</font> <font color="blue">±_2</font> <font color="blue">17_2</font> <font color="blue">mg_2</font> <font color="blue">/_2</font> <font color="blue">dl_2</font> <font color="blue">;_2</font> <font color="blue">p_2</font> <font color="blue">=_2</font> <font color="blue">0.001_2</font> <font color="blue">)_2</font> <font color="blue">._2</font> <font color="blue">Patients_3</font> <font color="blue">with_3</font> <font color="blue">spotty_3</font> <font color="blue">calcification_3</font> demonstrated a <font color="blue">greater_1</font> <font color="blue">percent_1</font> <font color="blue">atheroma_1</font> <font color="blue">volume_1</font> <font color="blue">(_1</font> <font color="blue">PAV_1</font> <font color="blue">)_1</font> <font color="blue">(_1</font> <font color="blue">36.0_1</font> <font color="blue">±_1</font> <font color="blue">7.6%_1</font> <font color="blue">vs._1</font> <font color="blue">29.0_1</font> <font color="blue">±_1</font> <font color="blue">8.5%_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue"><_1</font> <font color="blue">0.001_1</font> <font color="blue">)_1</font> <font color="blue">and_1</font> <font color="blue">total_1</font> <font color="blue">atheroma_1</font> <font color="blue">volume_1</font> <font color="blue">(_1</font> <font color="blue">174.6_1</font> <font color="blue">±_1</font> <font color="blue">71.9_1</font> <font color="blue">mm(3_1</font> <font color="blue">)_1</font> <font color="blue">vs._1</font> <font color="blue">133.9_1</font> <font color="blue">±_1</font> <font color="blue">64.9_1</font> <font color="blue">mm(3_1</font> <font color="blue">)_1</font> <font color="blue">;_1</font> <font color="blue">p_1</font> <font color="blue"><_1</font> <font color="blue">0.001_1</font> <font color="blue">)_1</font> <font color="blue">._1</font> On serial evaluation , spotty calcification was associated with greater progression of PAV ( + 0.43 ± 0.07% vs. + 0.02 ± 0.11% ; p = 0.002 ) . Although intensive low - density lipoprotein cholesterol and blood pressure lowering therapy slowed disease progression , these efficacies were attenuated in <font color="blue">patients_2</font> <font color="blue">with_2</font> <font color="blue">spotty_2</font> <font color="blue">calcification_2</font> <font color="blue">._2</font> 
<br> CONCLUSIONS The presence of spotty calcification is associated with more extensive and diffuse coronary atherosclerosis and accelerated disease progression despite use of medical therapies .